Cis-regulatory mechanisms governing stem and progenitor cell transitions

Science Advances

Volumn 1, Issue 8, 2015, Pages

  Johnson, Kirby D ^a,b   Kong, Guangyao ^b,c   Gao, Xin ^a,b   Chang, Yuan I ^b,c   Hewitt, Kyle J ^a,b   Sanalkumar, Rajendran ^a,b   Prathibha, Rajalekshmi ^a,b   Ranheim, Erik A ^d   Dewey, Colin N ^d   Zhang, Jing ^b,c   Bresnick, Emery H ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; MAMMALS;

ACUTE MYELOID LEUKEMIA; DISEASE PHENOTYPES; EMBRYONIC LETHALITY; HEMATOPOIETIC STEM CELLS; MYELODYSPLASTIC SYNDROMES; PHENOTYPIC DIVERSITY; PHYSIOLOGICAL ACTIVITY; REGULATORY MECHANISM;

STEM CELLS;

EID: 84960828861     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1500503     Document Type: Article

References (58)

1. F. Yue, Y. Cheng, A. Breschi, J. Vierstra, W. Wu, T. Ryba, R. Sandstrom, Z. Ma, C. Davis, B. D. Pope, Y. Shen, D. D. Pervouchine, S. Djebali, R. E. Thurman, R. Kaul, E. Rynes, A. Kirilusha, G. K. Marinov, B. A. Williams, D. Trout, H. Amrhein, K. Fisher-Aylor, I. Antoshechkin, G. DeSalvo, L.-H. See, M. Fastuca, J. Drenkow, C. Zaleski, A. Dobin, P. Prieto, J. Lagarde, G. Bussotti, A. Tanzer, O. Denas, K. Li, M. A. Bender, M. Zhang, R. Byron, M. T. Groudine, D. McCleary, L. Pham, Z. Ye, S. Kuan, L. Edsall, Y.-C. Wu, M. D. Rasmussen, M. S. Bansal, M. Kellis, C. A. Keller, C. S. Morrissey, T. Mishra, D. Jain, N. Dogan, R. S. Harris, P. Cayting, T. Kawli, A. P. Boyle, G. Euskirchen, A. Kundaje, S. Lin, Y. Lin, C. Jansen, V. S. Malladi, M. S. Cline, D. T. Erickson, V. M. Kirkup, K. Learned, C. A. Sloan, K. R. Rosenbloom, B. Lacerda de Sousa, K. Beal, M. Pignatelli, P. Flicek, J. Lian, T. Kahveci, D. Lee, W. J. Kent, M. R. Santos, J. Herrero, C. Notredame, A. Johnson, S. Vong, K. Lee, D. Bates, F. Neri, M. Diegel, T. Canfield, P. J. Sabo, M. S. Wilken, T. A. Reh, E. Giste, A. Shafer, T. Kutyavin, E. Haugen, D. Dunn, A. P. Reynolds, S. Neph, R. Humbert, R. Scott Hansen, M. De Bruijn, L. Selleri, A. Rudensky, S. Josefowicz, R. Samstein, E. E. Eichler, S. H. Orkin, D. Levasseur, T. Papayannopoulou, K.-H. Chang, A. Skoultchi, S. Gosh, C. Disteche, P. Treuting, Y. Wang, M. J. Weiss, G. A. Blobel, X. Cao, S. Zhong, T. Wang, P. J. Good, R. F. Lowdon, L. B. Adams, X.-Q. Zhou, M. J. Pazin, E. A. Feingold, B. Wold, J. Taylor, A. Mortazavi, S. M. Weissman, J. A. Stamatoyannopoulos, M. P. Snyder, R. Guigo, T. R. Gingeras, D. M. Gilbert, R. C. Hardison, M. A. Beer, B. Ren, The Mouse ENCODE Consortium, A comparative encyclopedia of DNA elements in the mouse genome. Nature 515, 355-364 (2014).
2. M. Kellis, B. Wold, M. P. Snyder, B. E. Bernstein, A. Kundaje, G. K. Marinov, L. D. Ward, E. Birney, G. E. Crawford, J. Dekker, I. Dunham, L. L. Elnitski, P. J. Farnham, E. A. Feingold, M. Gerstein, M. C. Giddings, D. M. Gilbert, T. R. Gingeras, E. D. Green, R. Guigo, T. Hubbard, J. Kent, J. D. Lieb, R. M. Myers, M. J. Pazin, B. Ren, J. A. Stamatoyannopoulos, Z. Weng, K. P. White, R. C. Hardison, Defining functional DNA elements in the human genome. Proc. Natl. Acad. Sci. U.S.A. 111, 6131-6138 (2014).
3. F. Y. Tsai, G. Keller, F. C. Kuo, M. Weiss, J. Chen, M. Rosenblatt, F. W. Alt, S. H. Orkin, An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226 (1994).
4. F.-Y. Tsai, S. H. Orkin, Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89, 3636-3643 (1997).
5. E. de Pater, P. Kaimakis, C. S. Vink, T. Yokomizo, T. Yamada-Inagawa, R. van der Liden, P. S. Kartalaei, S. A. Camper, N. Speck, E. Dzierzak, Gata2 is required for HSC generation and survival. J. Exp. Med. 210, 2843-2850 (2013).
6. K. C. Lim, T. Hosoya, W. Brandt, C. J. Ku, S. Hosoya-Ohmura, S. A. Camper, M. Yamamoto, J. D. Engel, Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J. Clin. Invest. 122, 3705-3717 (2012).
7. E. H. Bresnick, H. Y. Lee, T. Fujiwara, K. D. Johnson, S. Keles, GATA switches as developmental drivers. J. Biol. Chem. 285, 31087-31093 (2010).
8. A. W. DeVilbiss, R. Sanalkumar, K. D. Johnson, S. Keles, E. H. Bresnick, Hematopoietic transcriptional mechanisms: From locus-specific to genome-wide vantage points. Exp. Hematol. 42, 618-629 (2014).
9. J. W. Snow, J. J. Trowbridge, T. Fujiwara, N. E. Emambokus, J. A. Grass, S. H. Orkin, E. H. Bresnick, A single cis element maintains repression of the key developmental regulator Gata2. PLOS Genet. 6, e1001103 (2010).
10. J. W. Snow, J. J. Trowbridge, K. D. Johnson, T. Fujiwara, N. E. Emambokus, J. A. Grass, S. H. Orkin, E. H. Bresnick, Context-dependent function of "GATA switch" sites in vivo. Blood 117, 4769-4772 (2011).
11. K. D. Johnson, A. P. Hsu, M. J. Ryu, J. Wang, X. Gao, M. E. Boyer, Y. Liu, Y. Lee, K. R. Calvo, S. Keles, J. Zhang, S. M. Holland, E. H. Bresnick, Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J. Clin. Invest. 122, 3692-3704 (2012).
12. R. Sanalkumar, K. D. Johnson, X. Gao, M. E. Boyer, Y. I. Chang, K. J. Hewitt, J. Zhang, E. H. Bresnick, Mechanism governing a stem cell-generating cis-regulatory element. Proc. Natl. Acad. Sci. U. S. A. 111, E1091-E1100 (2014).
13. X. Gao, K. D. Johnson, Y. I. Chang, M. E. Boyer, C. N. Dewey, J. Zhang, E. H. Bresnick, Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. J. Exp. Med. 210, 2833-2842 (2013).
14. M. Luesink, I. H. Hollink, V. H. van der Velden, R. H. Knops, J. B. Boezeman, V. de Haas, J. Trka, A. Baruchel, D. Reinhardt, B. A. van der Reijden, M. M. van den Heuvel-Eibrink, C. M. Zwaan, J. H. Jansen, High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Blood 120, 2064-2075 (2012).
15. C. Vicente, I. Vazquez, A. Conchillo, M. A. García-Sánchez, N. Marcotegui, O. Fuster, M. González, M. J. Calasanz, I. Lahortiga, M. D. Odero, Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia 26, 550-554 (2012).
16. M. A. Spinner, L. A. Sanchez, A. P. Hsu, P. A. Shaw, C. S. Zerbe, K. R. Calvo, D. C. Arthur, W. Gu, C. M. Gould, C. C. Brewer, E.W. Cowen, A. F. Freeman, K.N. Olivier, G. Uzel, A. M. Zelazny, J. R. Daub, C. D. Spalding, R. J. Claypool, N. K. Giri, B. P. Alter, E. M. Mace, J. S. Orange, J. Cuellar-Rodriguez, D. D. Hickstein, S. M. Holland, GATA2 deficiency: A protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123, 809-821 (2014).
17. A. P. Hsu, E. P. Sampaio, J. Khan, K. R. Calvo, J. E. Lemieux, S. Y. Patel, D. M. Frucht, D. C. Vinh, R. D. Auth, A. F. Freeman, K. N. Olivier, G. Uzel, C. S. Zerbe, C. Spalding, S. Pittaluga, M. Raffeld, D. B. Kuhns, L. Ding, M. L. Paulson, B. E. Marciano, J. C. Gea-Banacloche, J. S. Orange, J. Cuellar-Rodriguez, D. D. Hickstein, S. M. Holland, Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118, 2653-2655 (2011).
18. R. E. Dickinson, H. Griffin, V. Bigley, L. N. Reynard, R. Hussain, M. Haniffa, J. H. Lakey, T. Rahman, X. N. Wang, N. McGovern, S. Pagan, S. Cookson, D. McDonald, I. Chua, J. Wallis, A. Cant, M. Wright, B. Keavney, P. F. Chinnery, J. Loughlin, S. Hambleton, M. Santibanez-Koref, M. Collin, Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118, 2656-2658 (2011).
19. C. N. Hahn, C. E. Chong, C. L. Carmichael, E. J. Wilkins, P. J. Brautigan, X. C. Li, M. Babic, M. Lin, A. Carmagnac, Y. K. Lee, C. H. Kok, L. Gagliardi, K. L. Friend, P. G. Ekert, C. M. Butcher, A. L. Brown, I. D. Lewis, LB To, A. E. Timms, J. Storek, S. Moore, M. Altree, R. Escher, P. G. Bardy, G. K. Suthers, R. J. DAndrea, M. S. Horwitz, H. S. Scott, Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012-1017 (2011).
20. P. Ostergaard, M. A. Simpson, F. C. Connell, C. G. Steward, G. Brice, W. J. Woollard, D. Dafou, T. Kilo, S. Smithson, P. Lunt, V. A. Murday, S. Hodgson, R. Keenan, D. T. Pilz, I. Martinez-Corral, T. Makinen, P. S. Mortimer, S. Jeffery, R. C. Trembath, S. Mansour, Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 43, 929-931 (2011).
21. A. P. Hsu, K. D. Johnson, E. L. Falcone, R. Sanalkumar, L. Sanchez, D. D. Hickstein, J. Cuellar-Rodriguez, J. E. Lemieux, C. S. Zerbe, E. H. Bresnick, S. M. Holland, GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 121, 3830-3837, S3831-S3837 (2013).
22. J. A. Grass, H. Jing, S. I. Kim, M. L. Martowicz, S. Pal, G. A. Blobel, E. H. Bresnick, Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol. Cell. Biol. 26, 7056-7067 (2006).
23. C. Vicente, A. Conchillo, M. A. Garcia-Sanchez, M. D. Odero, The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit. Rev. Oncol. Hematol. 82, 1-17 (2012).
24. H. Yamazaki, M. Suzuki, A. Otsuki, R. Shimizu, E. H. Bresnick, J. D. Engel, M. Yamamoto, A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Cancer Cell 25, 415-427 (2014).
25. S. Gröschel, M. A. Sanders, R. Hoogenboezem, E. de Wit, B. A. Bouwman, C. Erpelinck, V. H. van der Velden, M. Havermans, R. Avellino, K. van Lom, E. J. Rombouts, M. van Duin, K. Döhner, H. B. Beverloo, J. E. Bradner, H. Döhner, B. Löwenberg, P. J. Valk, E. M. Bindels, W. de Laat, R. Delwel, A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 157, 369-381 (2014).
26. Y. Fujiwara, C. P. Browne, K. Cunniff, S. C. Goff, S. H. Orkin, Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. U.S.A. 93, 12355-12358 (1996).
27. I. A. Wadman, H. Osada, G. G. Grütz, A. D. Agulnick, H. Westphal, A. Forster, T. H. Rabbitts, The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16, 3145-3157 (1997).
28. R. J. Wozniak, S. Keles, J. J. Lugus, K. H. Young, M. E. Boyer, T. M. Tran, K. Choi, E. H. Bresnick, Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis. Mol. Cell. Biol. 28, 6681-6694 (2008).
29. D. Traver, T. Miyamoto, J. Christensen, J. Iwasaki-Arai, K. Akashi, I. L. Weissman, Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets. Blood 98, 627-635 (2001).
30. K. Miyawaki, Y. Arinobu, H. Iwasaki, K. Kohno, H. Tsuzuki, T. Iino, T. Shima, Y. Kikushige, K. Takenaka, T. Miyamoto, K. Akashi, CD41 marks the initial myelo-erythroid lineage specification in adult mouse hematopoiesis: Redefinition of murine common myeloid progenitor. Stem Cells 33, 976-987 (2014).
31. R. Yamamoto, Y. Morita, J. Ooehara, S. Hamanaka, M. Onodera, K. L. Rudolph, H. Ema, H. Nakauchi, Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 154, 1112-1126 (2013).
32. J. Sun, A. Ramos, B. Chapman, J. B. Johnnidis, L. Le, Y. J. Ho, A. Klein, O. Hofmann, F. D. Camargo, Clonal dynamics of native haematopoiesis. Nature 514, 322-327 (2014).
33. J. F. DiMartino, L. Selleri, D. Traver, M. T. Firpo, J. Rhee, R. Warnke, S. OGorman, I. L. Weissman, M. L. Cleary, The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98, 618-626 (2001).
34. T. Evans, G. Felsenfeld, The erythroid-specific transcription factor eryf1: A new finger protein. Cell 58, 877-885 (1989).
35. S. F. Tsai, D. I. Martin, L. I. Zon, A. D. D'Andrea, G. G. Wong, S. H. Orkin, Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339, 446-451 (1989).
36. K. Keeshan, Y. He, B. J. Wouters, O. Shestova, L. Xu, H. Sai, C. G. Rodriguez, I. Maillard, J. W. Tobias, P. Valk, M. Carroll, J. C. Aster, R. Delwel, W. S. Pear, Tribbles homolog 2 inactivates C/EBPa and causes acute myelogenous leukemia. Cancer Cell 10, 401-411 (2006).
37. J. M. Beekman, L. P. Verhagen, N. Geijsen, P. J. Coffer, Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output. Blood 114, 3917-3927 (2009).
38. X. D. Yang, W. Ai, S. Asfaha, G. Bhagat, R. A. Friedman, G. Jin, H. Park, B. Shykind, T. G. Diacovo, A. Falus, T. C. Wang, Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat. Med. 17, 87-95 (2011).
39. T. Fujino, J. Kondo, M. Ishikawa, K. Morikawa, T. T. Yamamoto, Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J. Biol. Chem. 276, 11420-11426 (2001).
40. C. Betsholtz, Physiology: Double function at the blood-brain barrier. Nature 509, 432-433 (2014).
41. P. H. Weinstock, S. Levak-Frank, L. C. Hudgins, H. Radner, J. M. Friedman, R. Zechner, J. L. Breslow, Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc. Natl. Acad. Sci. U.S.A. 94, 10261-10266 (1997).
42. A. W. DeVilbiss, M. E. Boyer, E. H. Bresnick, Establishing a hematopoietic genetic network through locus-specific integration of chromatin regulators. Proc. Natl. Acad. Sci. U.S.A. 110, E3398-E3407 (2013).
43. J. C. Walsh, R. P. DeKoter, H. J. Lee, E. D. Smith, D. W. Lancki, M. F. Gurish, D. S. Friend, R. L. Stevens, J. Anastasi, H. Singh, Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17, 665-676 (2002).
44. R. E. Dickinson, P. Milne, L. Jardine, S. Zandi, S. I. Swierczek, N. McGovern, S. Cookson, Z. Ferozepurwalla, A. Langridge, S. Pagan, A. Gennery, T. Heiskanen-Kosma, S. Hämäläinen, M. Seppänen, M. Helbert, E. Tholouli, E. Gambineri, S. Reykdal, M. Gottfreǒsson, J. E. Thaventhiran, E. Morris, G. Hirschfield, A. G. Richter, S. Jolles, C. M. Bacon, S. Hambleton, M. Haniffa, Y. Bryceson, C. Allen, J. T. Prchal, J. E. Dick, V. Bigley, M. Collin, The evolution of cellular deficiency in GATA2 mutation. Blood 123, 863-874 (2014).
45. N. Goardon, E. Marchi, A. Atzberger, L. Quek, A. Schuh, S. Soneji, P. Woll, A. Mead, K. A. Alford, R. Rout, S. Chaudhury, A. Gilkes, S. Knapper, K. Beldjord, S. Begum, S. Rose, N. Geddes, M. Griffiths, G. Standen, A. Sternberg, J. Cavenagh, H. Hunter, D. Bowen, S. Killick, L. Robinson, A. Price, E. Macintyre, P. Virgo, A. Burnett, C. Craddock, T. Enver, S. E. Jacobsen, C. Porcher, P. Vyas, Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138-152 (2011).
46. B. J. Huntly, H. Shigematsu, K. Deguchi, B. H. Lee, S. Mizuno, N. Duclos, R. Rowan, S. Amaral, D. Curley, I. R. Williams, K. Akashi, D. G. Gilliland, MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6, 587-596 (2004).
47. A. V. Krivtsov, D. Twomey, Z. Feng, M. C. Stubbs, Y. Wang, J. Faber, J. E. Levine, J. Wang, W. C. Hahn, D. G. Gilliland, T. R. Golub, S. A. Armstrong, Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818-822 (2006).
48. P. Kirstetter, M. B. Schuster, O. Bereshchenko, S. Moore, H. Dvinge, E. Kurz, K. Theilgaard-Mönch, R. Mansson, T. A. Pedersen, T. Pabst, E. Schrock, B. T. Porse, S. E. Jacobsen, P. Bertone, D. G. Tenen, C. Nerlov, Modeling of C/EBPa mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 13, 299-310 (2008).
49. M. Celton, A. Forest, G. Gosse, S. Lemieux, J. Hebert, G. Sauvageau, B. T. Wilhelm, Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia. Leukemia 28, 1617-1626 (2014).
50. M. S. Kumar, D. C. Hancock, M. Molina-Arcas, M. Steckel, P. East, M. Diefenbacher, E. Armenteros-Monterroso, F. Lassailly, N. Matthews, E. Nye, G. Stamp, A. Behrens, J. Downward, The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 149, 642-655 (2012).
51. S. R. Plymate, R. S. Bhatt, S. P. Balk, Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2. Cancer Cell 27, 158-159 (2015).
52. M. A. Charles, T. L. Saunders, W. M. Wood, K. Owens, A. F. Parlow, S. A. Camper, E. C. Ridgway, D. F. Gordon, Pituitary-specific Gata2 knockout: Effects on gonadotrope and thyrotrope function. Mol. Endocrinol. 20, 1366-1377 (2006).
53. S. E. Craven, K. C. Lim, W. Ye, J. D. Engel, F. de Sauvage, A. Rosenthal, Gata2 specifies serotonergic neurons downstream of sonic hedgehog. Development 131, 1165-1173 (2004).
54. T. Yokomizo, T. Yamada-Inagawa, A. D. Yzaguirre, M. J. Chen, N. A. Speck, E. Dzierzak, Whole-mount three-dimensional imaging of internally localized immunostained cells within mouse embryos. Nat. Protoc. 7, 421-431 (2012).
55. J. Zhang, J. Wang, Y. Liu, H. Sidik, K. H. Young, H. F. Lodish, M. D. Fleming, Oncogenic Kras-induced leukemogeneis: Hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation. Blood 113, 1304-1314 (2009).
56. B. Li, C. N. Dewey, RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
57. M. I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
58. N. K. Wilson, S. D. Foster, X. Wang, K. Knezevic, J. Schütte, P. Kaimakis, P. M. Chilarska, S. Kinston, W. H. Ouwehand, E. Dzierzak, J. E. Pimanda, M. F. de Bruijn, B. Göttgens, Combinatorial transcriptional control in blood stem/progenitor cells: Genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7, 532-544 (2010).